Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-24-003336

Chief Executive Officer acquired 73,947 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-12 Grant or award : show line 1 in the form +73,947 84,400 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-12 Grant or award : show line 2 in the form Stock Option (right to buy) +73,947 73,947 D
Loading xslF345X05/doc4.xml…